Ciaffoni Joseph
SEC CIK 1443841 · EDGAR
BoughtSold
Most active insiders at INDV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Heidbreder Christian | CSO | — | $1.47M |
| 2 | Preblick Ryan | CFO | — | $1.36M |
| 3 | Anderson Woodrow D | CAO | $108.0K | — |
| 4 | Wheadon David E. | Dir | $62.7K | — |
| 5 | Kingsley Stuart A | Dir | $30.0K | — |
| 6 | Ryan Barbara | Dir | $28.7K | — |
| 7 | Humphreys Keith | Dir | $27.4K | — |
| 8 | Stejbach Mark | Dir | $27.4K | — |
| 9 | NINIVAGGI DANIEL A | Dir | $27.4K | — |
| 10 | Barry Patrick A | Chief Commercial Off | — | — |
| 13 | Ciaffoni Joseph | CEO, Dir | — | — |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:24 | 2026-06-22 | INDV | Indivior Pharmaceuticals, Inc. | Ciaffoni Joseph | CEO, Dir | M - OptEx | — | +1.27M | 1.40M | +932% | — |
| D | 2026-06-23 17:24 | 2026-06-22 | INDV | Indivior Pharmaceuticals, Inc. | Ciaffoni Joseph | CEO, Dir | F - Tax | $38.32 | -612.5K | 790.3K | -44% | -$23.47M |
| 2026-02-12 | 2026-02-10 | INDV | Indivior Pharmaceuticals, Inc. | Ciaffoni Joseph | CEO, Dir | A - Grant | $0.00 | +80.0K | 136.0K | +143% | $0 | |
| M | 2024-02-14 | 2024-02-12 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | A - Grant | $0.00 | +298.7K | 573.7K | +109% | $0 |
| M | 2024-02-14 | 2024-02-12 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | F - Tax | $33.70 | -128.9K | 526.3K | -20% | -$4.34M |
| D | 2023-12-22 | 2023-12-21 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale+OE | $30.38 | -4,357 | 275.0K | -2% | -$132.4K |
| D | 2023-12-22 | 2023-12-21 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $21.34 | +4,357 | 279.4K | +2% | +$93.0K |
| DM | 2023-12-20 | 2023-12-18+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale+OE | $30.18 | -68.8K | 275.0K | -20% | -$2.08M |
| DM | 2023-12-20 | 2023-12-18+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $21.34 | +68.8K | 302.8K | +29% | +$1.47M |
| M | 2023-06-02 | 2023-06-01+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale | $21.85 | -62.5K | 275.0K | -19% | -$1.37M |
| M | 2023-06-01 | 2023-05-30+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale | $21.88 | -62.5K | 337.5K | -16% | -$1.37M |
| D | 2023-02-14 | 2023-02-13 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $15.90 | +11.2K | 411.3K | +3% | +$178.9K |
| D | 2023-02-14 | 2023-02-13 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale+OE | $26.88 | -11.2K | 400.1K | -3% | -$302.4K |
| DM | 2023-02-14 | 2023-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | F - Tax | $26.75 | -103.9K | 400.1K | -21% | -$2.78M |
| DM | 2023-02-14 | 2023-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | A - Grant | $0.00 | +255.2K | 366.2K | +230% | $0 |
| M | 2022-12-27 | 2022-12-22+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale | $23.67 | -2,461 | 251.1K | -1.0% | -$58.3K |
| M | 2022-12-21 | 2022-12-19+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale | $23.08 | -17.8K | 251.2K | -7% | -$411.8K |
| D | 2022-12-05 | 2022-12-01 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $15.90 | +76.7K | 400.1K | +24% | +$1.22M |
| DM | 2022-12-05 | 2022-12-01+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale+OE | $22.72 | -131.1K | 269.1K | -33% | -$2.98M |
| D | 2022-11-30 | 2022-11-28 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $15.90 | +43 | 323.5K | +0.0% | +$683.70 |
| D | 2022-11-30 | 2022-11-28 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale+OE | $22.00 | -43 | 323.5K | -0.0% | -$946 |
| D | 2022-11-25 | 2022-11-22 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale+OE | $22.00 | -65 | 323.5K | -0.0% | -$1,430 |
| D | 2022-11-25 | 2022-11-22 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $15.90 | +65 | 323.5K | +0.0% | +$1,034 |
| D | 2022-11-22 | 2022-11-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | M - OptEx | $15.90 | +1,989 | 325.4K | +0.6% | +$31.6K |
| D | 2022-11-22 | 2022-11-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale+OE | $22.02 | -1,989 | 323.5K | -0.6% | -$43.8K |
| 2022-07-06 | 2022-07-01 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | F - Tax | $18.16 | -1,394 | 323.5K | -0.4% | -$25.3K | |
| M | 2022-03-03 | 2022-03-01 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | S - Sale | $18.47 | -76.1K | 324.8K | -19% | -$1.41M |
| M | 2022-02-14 | 2022-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | F - Tax | $17.63 | -53.0K | 429.8K | -11% | -$934.3K |
| M | 2022-02-14 | 2022-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | A - Grant | $0.00 | +190.0K | 388.9K | +96% | $0 |
| 2022-01-05 | 2022-01-03 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | F - Tax | $18.68 | -1,090 | 263.9K | -0.4% | -$20.4K | |
| 2021-08-12 | 2021-08-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | F - Tax | $19.03 | -1,386 | 265.0K | -0.5% | -$26.4K | |
| 2021-07-06 | 2021-07-01 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Ciaffoni Joseph | Pres, CEO, Dir | F - Tax | $23.99 | -1,394 | 266.4K | -0.5% | -$33.4K |
Purchase Sale Sale after option exercise All abbreviations